The use of bedaquiline in children in the treatment of multidrug-resistant tuberculosis
BACKGROUND: The treatment of multidrug-resistant tuberculosis (MDR-TB) in children is a difficult task, which is associated with the duration of therapy and the high frequency of severe adverse reactions. Non-injection regimens and shortened treatment courses are especially in demand in children, in...
Saved in:
| Main Authors: | Valentina Romanenko, Nadezhda Klevno, Alexey Kazakov, Ekaterina Sokolskaya, Anastasiya Gaida |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Journal of Global Antimicrobial Resistance |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213716524003576 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New drugs in the treatment of drug-resistant tuberculosis in children. Experience with the use of delamanid in combination with bedaquiline
by: Ekaterina Sokolskaya, et al.
Published: (2024-12-01) -
Pyrazinamide Resistance: A Major Cause of Switching Shorter to Longer Bedaquiline-based Regimens in Multidrug-resistant Tuberculosis Patients
by: Oki Nugraha Putra, et al.
Published: (2024-12-01) -
Treatment success and mortality among people with multi-drug resistant and rifampicin resistant-tuberculosis on bedaquiline-based regimen at three referral hospitals in Uganda: A retrospective analysis
by: Lodiong Jackson Dumo Lodiong, et al.
Published: (2024-12-01) -
Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region
by: G.B. Migliori, et al.
Published: (2024-03-01) -
Tuberculosis vaccines and therapeutic drug: challenges and future directions
by: Yajing An, et al.
Published: (2025-01-01)